Migraine and stroke: In search of shared mechanisms

Cephalalgia

Volumn 35, Issue 2, 2015, Pages 165-181

  Mawet, Jerome ^a,b,c   Kurth, Tobias ^d,e,f   Ayata, Cenk ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HÔPITAL LARIBOISIÈRE   (France)

^c DHU Neurovasc   (France)

^d INSERM   (France)

^e UNIVERSITÉ DE BORDEAUX   (France)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cerebrovascular disease; Ischemic stroke; Migraine; Migrainous infarct; Spreading depression

Indexed keywords

THROMBOPLASTIN;

ARTERY DISSECTION; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENDOTHELIAL DYSFUNCTION; GENE MUTATION; HUMAN; HYPERCOAGULABILITY; LIFESTYLE MODIFICATION; MIGRAINE; MIGRAINOUS INFARCTION; MONOGENIC DISORDER; NEUROIMAGING; ORAL CONTRACEPTIVE USE; PARADOXICAL EMBOLISM; PATIENT CARE; RARE DISEASE; REVASCULARIZATION; REVIEW; RISK FACTOR; SCREENING; SMOKING; TRANSIENT ISCHEMIC ATTACK; WHITE MATTER; WHITE MATTER LESION; COMPLICATION; PATHOPHYSIOLOGY;

HUMANS; MIGRAINE DISORDERS; STROKE;

EID: 84927746366     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102414550106     Document Type: Review

References (177)

1. Victor TW, Hu X, Campbell JC, et al. Migraine prevalence by age and sex in the United States: A life-span study. Cephalalgia 2010;30:1065-1072.
2. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013;33:629-808.
3. Silberstein SD. Migraine. Lancet 2004;363:381-391.
4. Leao A. Spreading depression of activity in the cerebral cortex. J Neurophysiol 1944;7:359-390.
5. Ayata C. Cortical spreading depression triggers migraine attack: Pro. Headache 2010;50:725-730.
6. Kurth T and Diener HC. Migraine and stroke: Perspectives for stroke physicians. Stroke 2012;43:3421-3426.
7. Bigal ME, Kurth T, Hu H, et al. Migraine and cardiovascular disease: Possible mechanisms of interaction. Neurology 2009;72:1864-1871.
8. Kurth T, Chabriat H and Bousser MG. Migraine and stroke: A complex association with clinical implications. Lancet Neurol 2012;11:92-100.
9. Pezzini A, Del Zotto E, Giossi A, et al. The migraineischemic stroke relation in young adults. Stroke Res Treat 2010;2011:304921.
10. Spector JT, Kahn SR, Jones MR, et al. Migraine headache and ischemic stroke risk: An updated meta-analysis. Am J Med 2010;123:612-624.
11. Kruit MC, Van Buchem MA, Hofman PA, et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004;291:427-434.
12. Bashir A, Lipton RB, Ashina S, et al. Migraine and structural changes in the brain: A systematic review and metaanalysis. Neurology 2013;81:1260-1268.
13. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics-2014 update: A report from the American Heart Association. Circulation 2014;129:e28-e292.
14. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095-2128.
15. Sacco S, Ornello R, Ripa P, et al. Migraine and hemorrhagic stroke: A meta-analysis. Stroke 2013;44:3032-3038.
16. Etminan M, Takkouche B, Isorna FC, et al. Risk of ischaemic stroke in people with migraine: Systematic review and meta-analysis of observational studies. BMJ 2005;330:63.
17. Schürks M, Rist PM, Bigal ME, et al. Migraine and cardiovascular disease: Systematic review and meta-analysis. BMJ 2009;339:b3914.
18. Kurth T, Gaziano JM, Cook NR, et al. Migraine and risk of cardiovascular disease in women. JAMA 2006;296:283-291.
19. MacClellan LR, Giles W, Cole J, et al. Probable migraine with visual aura and risk of ischemic stroke: The stroke prevention in young women study. Stroke 2007;38:2438-2445.
20. Rist PM, Buring JE, Kase CS, et al. Migraine and functional outcome from ischemic cerebral events in women. Circulation 2010;122:2551-2557.
21. Pezzini A, Grassi M, Lodigiani C, et al. Predictors of migraine subtypes in young adults with ischemic stroke: The Italian project on stroke in young adults. Stroke 2011;42:17-21.
22. Bigal ME, Kurth T, Santanello N, et al. Migraine and cardiovascular disease: A population-based study. Neurology 2010;74:628-635.
23. Wang YC, Lin CW, Ho YT, et al. Increased risk of ischemic heart disease in young patients with migraine: A population-based, propensity score-matched, longitudinal follow-up study. Int J Cardiol 2014;172:213-216.
24. Gudmundsson LS, Scher AI, Aspelund T, et al. Migraine with aura and risk of cardiovascular and all cause mortality in men and women: Prospective cohort study. BMJ 2010;341:c3966.
25. Schürks M, Rist PM, Shapiro RE, et al. Migraine and mortality: A systematic review and meta-analysis. Cephalalgia 2011;31:1301-1314.
26. Kruit MC, Launer LJ, Ferrari MD, et al. Infarcts in the posterior circulation territory in migraine. The populationbased MRI CAMERA study. Brain 2005;128:2068-2077.
27. Palm-Meinders IH, Koppen H, Terwindt GM, et al. Structural brain changes in migraine. JAMA 2012;308:1889-1897.
28. Scher AI, Gudmundsson LS, Sigurdsson S, et al. Migraine headache in middle age and late-life brain infarcts. JAMA 2009;301:2563-2570.
29. Kurth T, Mohamed S, Maillard P, et al. Headache, migraine, and structural brain lesions and function: Population based Epidemiology of Vascular Ageing-MRI study. BMJ 2011;342:c7357.
30. Putaala J, Kurkinen M, Tarvos V, et al. Silent brain infarcts and leukoaraiosis in young adults with firstever ischemic stroke. Neurology 2009;72:1823-1829.
31. Santamarta E, Meilán A, Saiz A, et al. Chronic migraine does not increase posterior circulation territory (PCT) infarct-like lesions. J Neurol Sci 2014;336:180-183.
32. Swartz RH and Kern RZ. Migraine is associated with magnetic resonance imaging white matter abnormalities: A meta-analysis. Arch Neurol 2004;61:1366-1368.
33. Kruit MC, Launer LJ, Ferrari MD, et al. Brain stem and cerebellar hyperintense lesions in migraine. Stroke 2006;37:1109-1112.
34. Hamedani AG, Rose KM, Peterlin BL, et al. Migraine and white matter hyperintensities: The ARIC MRI study. Neurology 2013;81:1308-1313.
35. Kurth T and Tzourio C. Migraine and cerebral infarctlike lesions on MRI: An observation, not a disease. JAMA 2009;301:2594-2595.
36. Chabriat H, Joutel A, Dichgans M, et al. Cadasil. Lancet Neurol 2009;8:643-653.
37. Vahedi K, Chabriat H, Levy C, et al. Migraine with aura and brain magnetic resonance imaging abnormalities in patients with CADASIL. Arch Neurol 2004;61:1237-1240.
38. Gould DB, Phalan FC, Breedveld GJ, et al. Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly. Science 2005;308:1167-1171.
39. Gould DB, Phalan FC, Van Mil SE, et al. Role of COL4A1 in small-vessel disease and hemorrhagic stroke. N Engl J Med 2006;354:1489-1496.
40. Lanfranconi S and Markus HS. COL4A1 mutations as a monogenic cause of cerebral small vessel disease: A systematic review. Stroke 2010;41:e513-e518.
41. Kuo DS, Labelle-Dumais C and Gould DB. COL4A1 and COL4A2 mutations and disease: Insights into pathogenic mechanisms and potential therapeutic targets. Hum Mol Genet 2012;21:R97-R110.
42. Richards A, Van Den Maagdenberg AM, Jen JC, et al. C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nat Genet 2007;39:1068-1070.
43. Terwindt GM, Haan J, Ophoff RA, et al. Clinical and genetic analysis of a large Dutch family with autosomal dominant vascular retinopathy, migraine and Raynaud's phenomenon. Brain 1998;121(Pt 2):303-316.
44. Kaufmann P, Engelstad K, Wei Y, et al. Natural history of MELAS associated with mitochondrial DNA m.3243A>G genotype. Neurology 2011;77:1965-1971.
45. Sproule DM and Kaufmann P. Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: Basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann N YAcad Sci 2008;1142:133-158.
46. Pavlakis SG, Phillips PC, DiMauro S, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: A distinctive clinical syndrome. Ann Neurol 1984;16:481-488.
47. Faughnan ME, Palda VA, Garcia-Tsao G, et al. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet 2011;48:73-87.
48. Steele JG, Nath PU, Burn J, et al. An association between migrainous aura and hereditary haemorrhagic telangiectasia. Headache 1993;33:145-148.
49. Post MC, Letteboer TG, Mager JJ, et al. A pulmonary right-to-left shunt in patients with hereditary hemorrhagic telangiectasia is associated with an increased prevalence of migraine. Chest 2005;128:2485-2489.
50. Post MC, Van Gent MW, Plokker HW, et al. Pulmonary arteriovenous malformations associated with migraine with aura. Eur Respir J 2009;34:882-887.
51. Thenganatt J, Schneiderman J, Hyland RH, et al. Migraines linked to intrapulmonary right-to-left shunt. Headache 2006;46:439-443.
52. Marziniak M, Jung A, Guralnik V, et al. An association of migraine with hereditary haemorrhagic telangiectasia independently of pulmonary right-to-left shunts. Cephalalgia 2009;29:76-81.
53. Galletti F, Sarchielli P, Hamam M, et al. Occipital arteriovenous malformations and migraine. Cephalalgia 2011;31:1320-1324.
54. Huang HY, Lin KH, Chen JC, et al. Type III Sturge-Weber syndrome with migraine-like attacks associated with prolonged visual aura. Headache 2013;53:845-849.
55. Zach V, Bezov D, Lipton RB, et al. Headache associated with moyamoya disease: A case story and literature review. J Headache Pain 2010;11:79-82.
56. Fere C. Note sur un cas de migraine ophtalmique à accès répé té s suivis de mort. Rev Med (Paris) 1883;194-201.
57. Laurell K, Artto V, Bendtsen L, et al. Migrainous infarction: A Nordic multicenter study. Eur J Neurol 2011;18:1220-1226.
58. Wolf ME, Szabo K, Griebe M, et al. Clinical and MRI characteristics of acute migrainous infarction. Neurology 2011;76:1911-1917.
59. Olesen J, Friberg L, Olsen TS, et al. Ischaemia-induced (symptomatic) migraine attacks may be more frequent than migraine-induced ischaemic insults. Brain 1993;116(Pt 1):187-202.
60. Nozari A, Dilekoz E, Sukhotinsky I, et al. Microemboli may link spreading depression, migraine aura, and patent foramen ovale. Ann Neurol 2010;67:221-229.
61. Dohmen C, Sakowitz OW, Fabricius M, et al. Spreading depolarizations occur in human ischemic stroke with high incidence. Ann Neurol 2008;63:720-728.
62. Santos E, Sánchez-Porras R, Dohmen C, et al. Spreading depolarizations in a case of migraine-related stroke. Cephalalgia 2012;32:433-436.
63. Piilgaard H and Lauritzen M. Persistent increase in oxygen consumption and impaired neurovascular coupling after spreading depression in rat neocortex. J Cereb Blood Flow Metab 2009;29:1517-1527.
64. Takano T, Tian GF, Peng W, et al. Cortical spreading depression causes and coincides with tissue hypoxia. Nat Neurosci 2007;10:754-762.
65. Yuzawa I, Sakadzic S, Srinivasan VJ, et al. Cortical spreading depression impairs oxygen delivery and metabolism in mice. J Cereb Blood Flow Metab 2012;32:376-386.
66. Nedergaard M and Hansen AJ. Spreading depression is not associated with neuronal injury in the normal brain. Brain Res 1988;449:395-398.
67. Attwell D, Buchan AM, Charpak S, et al. Glial and neuronal control of brain blood flow. Nature 2010;468:232-243.
68. Dreier JP. The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat Med 2011;17:439-447.
69. + is increased in the subarachnoid space. J Cereb Blood Flow Metab 1998;18:978-990.
70. Dreier JP, Ebert N, Priller J, et al. Products of hemolysis in the subarachnoid space inducing spreading ischemia in the cortex and focal necrosis in rats: A model for delayed ischemic neurological deficits after subarachnoid hemorrhage? J Neurosurg 2000;93:658-666.
71. Harrington MG, Fonteh AN, Arakaki X, et al. Capillary endothelial Na (+), K (+), ATPase transporter homeostasis and a new theory for migraine pathophysiology. Headache 2010;50:459-478.
72. Ducros A. Reversible cerebral vasoconstriction syndrome. Lancet Neurol 2012;11:906-917.
73. Hall GC, Brown MM, Mo J, et al. Triptans in migraine: The risks of stroke, cardiovascular disease, and death in practice. Neurology 2004;62:563-568.
74. Velentgas P, Cole JA, Mo J, et al. Severe vascular events in migraine patients. Headache 2004;44:642-651.
75. Wammes-Van Der Heijden EA, Rahimtoola H, Leufkens HG, et al. Risk of ischemic complications related to the intensity of triptan and ergotamine use. Neurology 2006;67:1128-1134.
76. Amin FM, Asghar MS, Hougaard A, et al. Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: A cross-sectional study. Lancet Neurol 2013;12:454-461.
77. Bigal ME. The association between migraine and obesity: Empty calories? Cephalalgia 2012;32:950-952.
78. Peterlin BL, Rosso AL, Williams MA, et al. Episodic migraine and obesity and the influence of age, race, and sex. Neurology 2013;81:1314-1321.
79. Chai NC, Scher AI, Moghekar A, et al. Obesity and headache: Part I-a systematic review of the epidemiology of obesity and headache. Headache 2014;54:219-234.
80. Vo M, Ainalem A, Qiu C, et al. Body mass index and adult weight gain among reproductive age women with migraine. Headache 2011;51:559-569.
81. Varkey E, Cider A, Carlsson J, et al. Exercise as migraine prophylaxis: A randomized study using relaxation and topiramate as controls. Cephalalgia 2011;31:1428-1438.
82. Le H, Tfelt-Hansen P, Skytthe A, et al. Association between migraine, lifestyle and socioeconomic factors: A population-based cross-sectional study. J Headache Pain 2011;12:157-172.
83. Peterlin BL, Tietjen GE, Gower BA, et al. Ictal adiponectin levels in episodic migraineurs: A randomized pilot trial. Headache 2013;53:474-490.
84. Cindy Chai N, Bond DS, Moghekar A, et al. Obesity and headache: Part II-potential mechanism and treatment considerations. Headache 2014;54:459-471.
85. Gudmundsson B, Olafsson E, Jakobsson F, et al. Prevalence of symptomatic Charcot-Marie-Tooth disease in Iceland: A study of a well-defined population. Neuroepidemiology 2010;34:13-17.
86. Scher AI, Terwindt GM, Picavet HS, et al. Cardiovascular risk factors and migraine: The GEM populationbased study. Neurology 2005;64:614-620.
87. Kurth T, Schürks M, Logroscino G, et al. Migraine, vascular risk, and cardiovascular events in women: Prospective cohort study. BMJ 2008;337:a636.
88. Modgill G, Jette N, Wang JL, et al. A population-based longitudinal community study of major depression and migraine. Headache 2012;52:422-432.
89. Rist PM, Schürks M, Buring JE, et al. Migraine, headache, and the risk of depression: Prospective cohort study. Cephalalgia 2013;33:1017-1025.
90. Pan A, Sun Q, Okereke OI, et al. Depression and risk of stroke morbidity and mortality: A meta-analysis and systematic review. JAMA 2011;306:1241-1249.
91. Stam AH, Weller CM, Janssens AC, et al. Migraine is not associated with enhanced atherosclerosis. Cephalalgia 2013;33:228-235.
92. Rist PM, Diener HC, Kurth T, et al. Migraine, migraine aura, and cervical artery dissection: A systematic review and meta-analysis. Cephalalgia 2011;31:886-896.
93. Metso TM, Tatlisumak T, Debette S, et al. Migraine in cervical artery dissection and ischemic stroke patients. Neurology 2012;78:1221-1228.
94. Mawet J, Boukobza M, Franc J, et al. Reversible cerebral vasoconstriction syndrome and cervical artery dissection in 20 patients. Neurology 2013;81:821-824.
95. Debette S. Pathophysiology and risk factors of cervical artery dissection: What have we learnt from large hospital-based cohorts? Curr Opin Neurol 2014;27:20-28.
96. Borgdorff P and Tangelder GJ. Migraine: Possible role of shear-induced platelet aggregation with serotonin release. Headache 2012;52:1298-1318.
97. Gursoy-Ozdemir Y, Qiu J, Matsuoka N, et al. Cortical spreading depression activates and upregulates MMP-9. J Clin Invest 2004;113:1447-1455.
98. Leira R, Sobrino T, Rodríguez-Yaúnéz M, et al. Mmp-9 immunoreactivity in acute migraine. Headache 2007;47:698-702.
99. Guillon B, Peynet J, Bertrand M, et al. Do extracellularmatrixregulating enzymes play a role in cervical artery dissection? Cerebrovasc Dis 2007;23:299-303.
100. Tzourio C, El Amrani M, Robert L, et al. Serum elastase activity is elevated in migraine. Ann Neurol 2000;47:648-651.
101. Cavestro C, Richetta L, L'episcopo MR, et al. Anatomical variants of the circle of Willis and brain lesions in migraineurs. Can J Neurol Sci 2011;38:494-499.
102. Ikeda K, Iwamoto K, Murata K, et al. Incomplete posterior circle of Willis in migraineurs with aura. Headache. Epub ahead of print 5 October 2009.
103. Bugnicourt JM, Garcia PY, Peltier J, et al. Incomplete posterior circle of Willis: A risk factor for migraine? Headache 2009;49:879-886.
104. Tietjen GE. Migraine as a systemic vasculopathy. Cephalalgia 2009;29:987-996.
105. Napoli R, Guardasole V, Zarra E, et al. Vascular smooth muscle cell dysfunction in patients with migraine. Neurology 2009;72:2111-2114.
106. Vanmolkot FH, Van Bortel LM and De Hoon JN. Altered arterial function in migraine of recent onset. Neurology 2007;68:1563-1570.
107. Yetkin E, Ozisik H, Ozcan C, et al. Increased dilator response to nitrate and decreased flow-mediated dilatation in migraineurs. Headache 2007;47:104-110.
108. Liman TG, Neeb L, Rosinski J, et al. Peripheral endothelial function and arterial stiffness in women with migraine with aura: A case-control study. Cephalalgia 2012;32:459-466.
109. Perko D, Pretnar-Oblak J, Šabović M, et al. Associations between cerebral and systemic endothelial function in migraine patients: A post-hoc study. BMC Neurol 2011;11:146.
110. Rodríguez-Osorio X, Sobrino T, Brea D, et al. Endothelial progenitor cells: A new key for endothelial dysfunction in migraine. Neurology 2012;79:474-479.
111. Vanmolkot FH and De Hoon JN. Endothelial function in migraine: A cross-sectional study. BMC Neurol 2010;10:119.
112. Fiermonte G, Annulli A and Pierelli F. Transcranial Doppler evaluation of cerebral hemodynamics in migraineurs during prophylactic treatment with flunarizine. Cephalalgia 1999;19:492-496.
113. Kastrup A, Thomas C, Hartmann C, et al. Cerebral blood flow and CO2 reactivity in interictal migraineurs: A transcranial Doppler study. Headache 1998;38:608-613.
114. Vernieri F, Tibuzzi F, Pasqualetti P, et al. Increased cerebral vasomotor reactivity in migraine with aura: An autoregulation disorder? A transcranial Doppler and near-infrared spectroscopy study. Cephalalgia 2008;28:689-695.
115. Akin A and Bilensoy D. Cerebrovascular reactivity to hypercapnia in migraine patients measured with nearinfrared spectroscopy. Brain Res 2006;1107:206-214.
116. Silvestrini M, Baruffaldi R, Bartolini M, et al. Basilar and middle cerebral artery reactivity in patients with migraine. Headache 2004;44:29-34.
117. Totaro R, Marini C, De Matteis G, et al. Cerebrovascular reactivity in migraine during headache-free intervals. Cephalalgia 1997;17:191-194.
118. Perko D, Pretnar-Oblak J, Šabović M, et al. Cerebrovascular reactivity to l-arginine in the anterior and posterior cerebral circulation in migraine patients. Acta Neurol Scand 2011;124:269-274.
119. Tietjen GE, Herial NA, White L, et al. Migraine and biomarkers of endothelial activation in young women. Stroke 2009;40:2977-2982.
120. Lee ST, Chu K, Jung KH, et al. Decreased number and function of endothelial progenitor cells in patients with migraine. Neurology 2008;70:1510-1517.
121. Tietjen GE, Al-Qasmi MM, Gunda P, et al. Sneddon's syndrome: Another migraine-stroke association? Cephalalgia 2006;26:225-232.
122. Hering-Hanit R, Friedman Z, Schlesinger I, et al. Evidence for activation of the coagulation system in migraine with aura. Cephalalgia 2001;21:137-139.
123. D'Amico D, Moschiano F, Leone M, et al. Genetic abnormalities of the protein C system: Shared risk factors in young adults with migraine with aura and with ischemic stroke? Cephalalgia 1998;18:618-621; discussion 591.
124. Ferrara M, Capozzi L, Bertocco F, et al. Thrombophilic gene mutations in children with migraine. Hematology 2012;17:115-117.
125. Corral J, Iniesta JA, Gonzaílez-Conejero R, et al. Migraine and prothrombotic genetic risk factors. Cephalalgia 1998;18:257-260.
126. Haan J, Kappelle LJ, Ferrari MD, et al. The transition G to A at position 20210 in the 3'-untranslated region of the prothrombin gene is not associated with migrainous infarction. Cephalalgia 1998;18:229-230.
127. Intiso D, Crociani P, Fogli D, et al. Occurrence of factor V Leiden mutation (Arg506Gln) and anticardiolipin antibodies in migraine patients. Neurol Sci 2002;22:455-458.
128. Rajan R, Ahluwalia J and Lal V. Prothrombotic states in migraine. Clin Appl Thromb Hemost. Epub ahead of print 1 May 2013.
129. Soriani S, Borgna-Pignatti C, Trabetti E, et al. Frequency of factor V Leiden in juvenile migraine with aura. Headache 1998;38:779-781.
130. Maitrot-Mantelet L, Horellou MH, Massiou H, et al. Should women suffering from migraine with aura be screened for biological thrombophilia? Results from a cross-sectional French study. Thromb Res 2014;133:714-718.
131. Martínez-Saínchez P, Martínez-Martínez M, Fuentes B, et al. Migraine and hypercoagulable states in ischemic stroke. Cephalalgia 2011;31:1609-1617.
132. Cavestro C, Micca G, Molinari F, et al. Migraineurs show a high prevalence of antiphospholipid antibodies. J Throm Haemost 2011;9:1350-1354.
133. Tjensvoll AB, Harboe E, Gøransson LG, et al. Migraine is frequent in patients with systemic lupus erythematosus: A case-control study. Cephalalgia 2011;31:401-408.
134. Michiels JJ, Berneman Z, Schroyens W, et al. Plateletmediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: A distinct aspirin-responsive and Coumadinresistant arterial thrombophilia. Platelets 2006;17:528-544.
135. Schurks M, Zee RY, Buring JE, et al. Interrelationships among the MTHFR 677C>T polymorphism, migraine, and cardiovascular disease. Neurology 2008;71:505-513.
136. Pezzini A, Grassi M, Del Zotto E, et al. Migraine mediates the influence of C677T MTHFR genotypes on ischemic stroke risk with a stroke-subtype effect. Stroke 2007;38:3145-3151.
137. Schürks M, Rist PM and Kurth T. MTHFR 677C>T and ACE D/I polymorphisms in migraine: A systematic review and meta-analysis. Headache 2010;50:588-599.
138. Schwedt TJ, Demaerschalk BM and Dodick DW. Patent foramen ovale and migraine: A quantitative systematic review. Cephalalgia 2008;28:531-540.
139. Wilmshurst PT, Pearson MJ, Nightingale S, et al. Inheritance of persistent foramen ovale and atrial septal defects and the relation to familial migraine with aura. Heart 2004;90:1315-1320.
140. Rigatelli G, Cardaioli P, Dell'Avvocata F, et al. May migraine post-patent foramen ovale closure sustain the microembolic genesis of cortical spread depression? Cardiovasc Revasc Med 2011;12:217-219.
141. Dowson A, Mullen MJ, Peatfield R, et al. Migraine Intervention with STARFlex Technology (MIST) trial: A prospective, multicenter, double-blind, shamcontrolled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation 2008;117:1397-1404.
142. Davis D, Gregson J, Willeit P, et al. Patent foramen ovale, ischemic stroke and migraine: Systematic review and stratified meta-analysis of association studies. Neuroepidemiology 2013;40:56-67.
143. Alsheikh-Ali AA, Thaler DE and Kent DM. Patent foramen ovale in cryptogenic stroke: Incidental or pathogenic? Stroke 2009;40:2349-2355.
144. Gillet JL, Donnet A, Lausecker M, et al. Pathophysiology of visual disturbances occurring after foam sclerotherapy. Phlebology 2010;25:261-266.
145. Sarvananthan T, Shepherd AC, Willenberg T, et al. Neurological complications of sclerotherapy for varicose veins. J Vasc Surg 2012;55:243-251.
146. Caputi L, Usai S, Carriero MR, et al. Microembolic air load during contrast-transcranial Doppler: A trigger for migraine with aura? Headache 2010;50:1320-1327.
147. Zaletel M, Zvan B, Kozelj M, et al. Migraine with aura induced by artificial microbubbles. Cephalalgia 2009;29:480-483.
148. Sevgi EB, Erdener SE, Demirci M, et al. Paradoxical air microembolism induces cerebral bioelectrical abnormalities and occasionally headache in patent foramen ovale patients with migraine. J Am Heart Assoc 2012;1:e001735.
149. De Ceuster L, Van Diepen T and Koehler PJ. Migraine with aura triggered by cardiac myxoma: Case report and literature review. Cephalalgia 2010;30:1396-1399.
150. Hasselblatt M, Köhler J, Volles E, et al. Simultaneous monitoring of endothelin-1 and vasopressin plasma levels in migraine. Neuroreport 1999;10:423-425.
151. Kallela M, Farkkila M, Saijonmaa O, et al. Endothelin in migraine patients. Cephalalgia 1998;18:329-332.
152. Farkkila M, Palo J, Saijonmaa O, et al. Raised plasma endothelin during acute migraine attack. Cephalalgia 1992;12:383-384; discussion 340.
153. Gallai V, Sarchielli P, Firenze C, et al. Endothelin 1 in migraine and tension-type headache. Acta Neurol Scand 1994;89:47-55.
154. Tzourio C, El Amrani M, Poirier O, et al. Association between migraine and endothelin type A receptor (ETA-231 A/G) gene polymorphism. Neurology 2001;56:1273-1277.
155. Frullini A, Felice F, Burchielli S, et al. High production of endothelin after foam sclerotherapy: A new pathogenetic hypothesis for neurological and visual disturbances after sclerotherapy. Phlebology 2011;26:203-208.
156. Frullini A, Barsotti MC, Santoni T, et al. Significant endothelin release in patients treated with foam sclerotherapy. Dermatol Surg 2012;38:741-747.
157. Dreier JP, Kleeberg J, Petzold G, et al. Endothelin-1 potently induces Leao's cortical spreading depression in vivo in the rat: A model for an endothelial trigger of migrainous aura? Brain 2002;125:102-112.
158. Kleeberg J, Petzold GC, Major S, et al. ET-1 induces cortical spreading depression via activation of the ETA receptor/phospholipase C pathway in vivo. Am J Physiol Heart Circ Physiol 2004;286:H1339-H1346.
159. Dreier JP, Kleeberg J, Alam M, et al. Endothelin-1-induced spreading depression in rats is associated with a microarea of selective neuronal necrosis. Exp Biol Med (Maywood) 2007;232:204-213.
160. Russell MB and Ducros A. Sporadic and familial hemiplegic migraine: Pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol 2011;10:457-470.
161. Tottene A, Conti R, Fabbro A, et al. Enhanced excitatory transmission at cortical synapses as the basis for facilitated spreading depression in Ca (v) 2.1 knockin migraine mice. Neuron 2009;61:762-773.
162. Moskowitz MA, Bolay H and Dalkara T. Deciphering migraine mechanisms: Clues from familial hemiplegic migraine genotypes. Ann Neurol 2004;55:276-280.
163. Eikermann-Haerter K, Dilekoz E, Kudo C, et al. Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1. J Clin Invest 2009;119:99-109.
164. Eikermann-Haerter K, Yuzawa I, Qin T, et al. Enhanced subcortical spreading depression in familial hemiplegic migraine type 1 mutant mice. J Neurosci 2011;31:5755-5763.
165. Eikermann-Haerter K, Lee JH, Yuzawa I, et al. Migraine mutations increase stroke vulnerability by facilitating ischemic depolarizations. Circulation 2012;125:335-345.
166. Nakamura H, Strong AJ, Dohmen C, et al. Spreading depolarizations cycle around and enlarge focal ischaemic brain lesions. Brain 2010;133:1994-2006.
167. Eikermann-Haerter K, Yuzawa I, Dilekoz E, et al. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy syndrome mutations increase susceptibility to spreading depression. Ann Neurol 2011;69:413-418.
168. Arboleda-Velasquez JF, Zhou Z, Shin HK, et al. Linking Notch signaling to ischemic stroke. Proc Natl Acad Sci U SA 2008;105:4856-4861.
169. Arboleda-Velasquez JF, Manent J, Lee JH, et al. Hypomorphic Notch 3 alleles link Notch signaling to ischemic cerebral small-vessel disease. Proc Natl Acad Sci U SA 2011;108:E128-E135.
170. Van Agtmael T, Bailey MA, Schlötzer-Schrehardt U, et al. Col4a1 mutation in mice causes defects in vascular function and low blood pressure associated with reduced red blood cell volume. Hum Mol Genet 2010;19:1119-1128.
171. Iizuka T, Sakai F, Ide T, et al. Regional cerebral blood flow and cerebrovascular reactivity during chronic stage of stroke-like episodes in MELAS-implication of neurovascular cellular mechanism. J Neurol Sci 2007;257:126-138.
172. Iizuka T, Sakai F, Suzuki N, et al. Neuronal hyperexcitability in stroke-like episodes of MELAS syndrome. Neurology 2002;59:816-824.
173. Koga Y, Akita Y, Junko N, et al. Endothelial dysfunction in MELAS improved by l-arginine supplementation. Neurology 2006;66:1766-1769.
174. Naini A, Kaufmann P, Shanske S, et al. Hypocitrullinemia in patients with MELAS: An insight into the "MELAS paradox". J Neurol Sci 2005;229-230:187-193.
175. Smith WS, Johnston SC, Skalabrin EJ, et al. Spinal manipulative therapy is an independent risk factor for vertebral artery dissection. Neurology 2003;60:1424-1428.
176. Rothwell DM, Bondy SJ and Williams JI. Chiropractic manipulation and stroke: A population-based casecontrol study. Stroke 2001;32:1054-1060.
177. Ayata C, Jin H, Kudo C, et al. Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol 2006;59:652-661.